This opportunity is no longer accepting applications.
grant NOT-AI-24-072

Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery

This grant opportunity aims to support early-stage research for creating new malaria vaccines or treatments using monoclonal antibodies. It focuses on developing combination vaccines, vaccines that provide broad protection, and improving how these products are delivered and made. The overall goal is to increase the number of potential options for preventing malaria worldwide.

The NOSI aims to support early-phase translational research to develop new malaria vaccine candidates or monoclonal antibody-based interventions. This includes research on combination vaccine concepts, broadly protective vaccines, and improved administration and manufacturability of products. Th…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Dates

Opportunity Released: November 20, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.